Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 218047
Company: GLAND
Company: GLAND
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/05/2024 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/218047Orig1s000ltr.pdf |
ERIBULIN MESYLATE
SOLUTION;INTRAVENOUS; 1MG/2ML (0.5MG/ML)
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 217250 | BAXTER HLTHCARE CORP |
ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 218743 | CHIA TAI TIANQING |
ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 218047 | GLAND |
ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 218281 | JIANGXI QINGFENG |
ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription | No | AP | 214850 | LONG GROVE PHARMS |
HALAVEN | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS | Prescription | Yes | AP | 201532 | EISAI INC |